ArrowMark Colorado Holdings’s Allergan plc AGN Stock Holding History

ArrowMark Colorado Holdings’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-28,318	Closed	-$4.72M	–	366
2018 Q2	$4.72M	Sell	28,318 -2,653	-9%	-$426K	0.04%	239
2018 Q1	$5.21M	Sell	30,971 -4,029	-12%	-$676K	0.05%	220
2017 Q4	$5.72M	Hold	35,000	–	–	0.06%	211
2017 Q3	$7.17M	Hold	35,000	–	–	0.08%	197
2017 Q2	$8.51M	Hold	35,000	–	–	0.11%	166
2017 Q1	$8.36M	Sell	35,000 -10,000	-22%	-$2.33M	0.11%	148
2016 Q4	$9.45M	Sell	45,000 -7,500	-14%	-$1.55M	0.15%	134
2016 Q3	$12.1M	Buy	52,500 +12,500	+31%	+$3.05M	0.22%	113
2016 Q2	$9.24M	Buy	+40,000	New	+$9.22M	0.19%	117

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ArrowMark Colorado Holdings's AGN Position: Q3 2018 in Review

ArrowMark Colorado Holdings sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 28,318 shares — an estimated $4.72M sold.

ArrowMark Colorado Holdings first reported a position in AGN in Q2 2016 and held it in 9 quarters. The position peaked at $12.1M in Q3 2016. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

ArrowMark Colorado Holdings reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
ArrowMark Colorado Holdings sold 28,318 Allergan plc shares in Q3 2018, an estimated $4.72M.
ArrowMark Colorado Holdings first reported a position in Allergan plc in Q2 2016 and held it in 9 quarters.
ArrowMark Colorado Holdings's Allergan plc position peaked at $12.1M in Q3 2016.
1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.